Capha Pharmaceuticals Inc.
Other OTCTotal Valuation
Capha Pharmaceuticals Inc. carries a market capitalization of 6,443.00, placing it among publicly traded companies globally.
| Market Cap | 6,443.00 |
| Enterprise Value | N/A |
Share Statistics
Capha Pharmaceuticals Inc. currently has 64.43M shares outstanding.
| Shares Outstanding | 64.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.00 |
| P/TBV Ratio | -0.01 |
| P/FCF Ratio | -0.15 |
| P/OCF Ratio | -0.15 |
Financial Position
Capha Pharmaceuticals Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1,664.67 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Capha Pharmaceuticals Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -58,481.00, while operating income came in at -58,703.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -58,703.00 |
| Pretax Income | -59,021.00 |
| Net Income | -59,021.00 |
| EBITDA | -58,481.00 |
| EBIT | -58,703.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Total book value stands at -4.29M, with working capital of -594,332.00 providing operational flexibility.
| Cash & Cash Equivalents | 3,377.00 |
| Total Debt | N/A |
| Net Debt | 586,191.00 |
| Equity (Book Value) | -4.29M |
| Book Value Per Share | -0.07 |
| Working Capital | -594,332.00 |
Cash Flow
Capha Pharmaceuticals Inc. produced -57,874.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -57,874.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -57,874.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -683.99 |
| FCF Yield | -659.75 |
Stock Splits
Capha Pharmaceuticals Inc.'s most recent stock split took place on August 29, 2014 with a 1:2 split ratio.
| Last Split Date | 8/29/2014 |
| Split Ratio | 1:2 |
Scores
Capha Pharmaceuticals Inc. posts an Altman Z-Score of -5,207.18, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5,207.18 |